Targeted KRAS Mutation Assessment on Patient Tumor Histologic Material in Real Time Diagnostics
Vassiliki Kotoula, Elpida Charalambous, Bart Biesmans et al. · 2009
Read Targeted KRAS Mutation Assessment on Patient Tumor Histologic Material in Real Time Diagnostics by Vassiliki Kotoula, Elpida Charalambous, Bart Biesmans et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007746.txt.
Description
Vassiliki Kotoula and co-authors published a study in PLOS ONE in 2009. It tackles a practical problem in cancer diagnosis. Doctors test tumor tissue for mutations in a gene called KRAS. The result can predict whether a treatment will work.
Routine tumor samples are fixed in formalin and embedded in paraffin, which damages DNA. The team assessed KRAS mutations on such real-world material. They used a sensitive real-time PCR method in a live diagnostic setting. Showing the test works on standard hospital samples is a key step. It brings mutation-guided treatment closer to everyday oncology practice.
Catalog record
| CREATOR | Vassiliki Kotoula, Elpida Charalambous, Bart Biesmans et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007746